Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
ZYDUS LIFESCIENCES LTD.
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE | BSE: 532321
Mid-range Performer
In 1 Starfolio Basket
Download real time
942.50
5.25
(
0.56
%)
966.4K
NSE+BSE Volume
NSE
28 Nov, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
TRADE STOCK
US FDA Approval
Zydus Life gets US FDA nod for Empagliflozin & Linagliptin tablets with a market size of $215.8 mn
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Earnings/Conference Calls
Zydus Lifesciences earnings concalls and investor presentations
All
News
Earnings Calls
Corporate Announcements
Research Reports
Is Cadila Healthcare Ltd. worth buying?
864 Votes:
Buy
81.94%
Sell
9.95%
Hold
8.1%
BUY
SELL
HOLD
RESEARCH REPORTS
Accumulate
SEE REPORTS >
07 Nov 2025
pdf
Zydus Lifesciences L..
by Prabhudas Lilladhar
| Target:
1020
| Upside:
8.22%
Buy
SEE REPORTS >
07 Nov 2025
pdf
Zydus Lifesciences L..
by Deven Choksey
| Target:
1121
| Upside:
18.94%
All reports of ZYDUSLIFE